Biokit
Biokit futureproofs diagnostics business and maximizes R&D spend through the introduction of IDBS E‑WorkBook.
Organizations need to capitalize on R&D data, and in today’s highly networked labs, collaboration is everything. Research teams, whatever their location, must be able to capture, secure, analyze and then share data quickly to accelerate the discovery process of new medicines and gain insights into complex scientific problems.
IDBS partners with global pharmaceutical companies, major biotechs, as well as smaller companies, enabling them to capture business critical scientific data, analyze it and then generate and share cross-experimental reports in a matter of hours rather than the current typical days, weeks or months.
Using the IDBS platform, pharmaceutical and biotech organizations can integrate data and process across every stage of the drug discovery process: supporting every discipline involved – chemistry, biology and analytical.
IDBS has the proven technology, expertise and experience and we have been successfully helping organizations to transform their research processes for new biological and chemical entities (NBE and NCE) for over 30 years.
We help organizations integrate data and processes across every stage of the drug discovery process.
With IDBS, you can deliver on-demand access to R&D information to people who need it, when they need it – enabling you to improve quality, optimize processes and increase efficiency. The end result? You can give valuable innovation time back to your scientists.
Our solutions span preclinical, analytical sciences, chemical sciences, and biomolecule research in a single system putting more of your data together for better insight and decision making.
Key benefit
Capture, analyze and share scientific data in hours not days or weeks
Key benefit
Increase collaboration within the organization and with outsourcing partners
Key benefit
Capitalize on intellectual property (IP) assets through the secure exchange of ideas and information
Key benefit
Manage contextualized data and gain valuable insight and understanding across the product and process lifecycle
Key benefit
Easily expand into new areas with our customer ready solutions
Key benefit
Integrates with lab instruments and technologies
Key benefit
Flexible, scalable and powerful enterprise-class software that enables you to start building your lab of the future
Key benefit
Secure environment for access to contextualized data irrespective of location
Key benefit
Painless implementation of SOP, QA, and QC procedures
Celera accelerates genetic marker research with IDBS, helping identify coronary heart disease biomarkers. IDBS’ translational research informatics platform provides flexible, workflow driven integration, analysis and visualization, accelerating the scientific understanding of biomarker data.
A biotech company focused on kidney disease implemented E-WorkBook and has seen improved data sharing with its external partners.
Improve data quality, productivity and compliance.
Customers and regulators expect the highest level of data integrity to get the most out of data and ensure compliance. Download the whitepaper to discover more.